Efficacy of MSC2156119J and c-Met activation status in patient-derived HCC xenograft models with low (IHC score = 0–1), intermediate (IHC score = 2), and high (IHC score = 3) c-Met levels. Here, MET is linked to hepatocellular carcinoma.